Latest

2 stories

Hide weekly roundups

Tuesday, October 13

FinancingSS Innovations International, Inc

SS Innovations issues $21.025 million convertible note to institutional investor

The Florida-based company closed a secured convertible note deal on October 9, 2026, raising $20 million in net purchase price under terms disclosed in a new SEC filing.

SEC filing

Friday, October 9

FinancingBambusa Therapeutics, Inc Decoy Therapeutics, Inc SS Innovations International, Inc

Bambusa Therapeutics files for IPO, discloses bispecific antibody data

The clinical-stage biopharmaceutical company filed an S-1 with the SEC on October 9, 2026 to list on Nasdaq under the ticker "BBTX."

SEC filing (2)